Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0105617 HYDROGEL CAPABLE OF BEING USED FOR SEAWATER DESALINATION AND PREPARATION METHOD THEREFOR
A hydrogel capable of desalinating seawater and a preparation method thereof. The hydrogel is a polymer polymerized by a monomer containing a hydrophilic group...
2018/0105616 TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING SAME
The present invention provides a transition metal compound, a catalyst composition comprising the same, and a method for producing an olefin polymer using the...
2018/0105615 ETHYLENE-VINYL ALCOHOL COPOLYMER, PROCESS FOR PRODUCING THE SAME, AND LAMINATE
An object of the invention is to provide an EVOH which has improved melt moldability and is excellent in terms of gas barrier property and secondary...
2018/0105614 TIRE MEMBER MANUFACTURING METHOD AND TIRE MANUFACTURING METHOD
A first tire member manufacturing method includes an operation in which a pre-coagulation rubber latex containing carbon black, for which a ratio of specific...
2018/0105613 ELIMINATION OF POLYMER FOULING IN FLUIDIZED BED GAS-PHASE FINES RECOVERY EDUCTORS
An eductor, a process and apparatus for gas phase polymerization of olefins in a polymerization reactor are disclosed. The process and apparatus employ an...
2018/0105612 TIRE MANUFACTURING METHOD
A tire manufacturing method includes making a master batch, using the master batch to make a rubber composition, and making a green tire. The master batch is...
2018/0105611 METHOD OF ELECTROCHEMICALLY MODIFYING SURFACE OF ELECTRODE USING DOPAMINE-HYALURONIC ACID CONJUGATES
Provided are a method of electrically modifying an electrode surface with dopamine-hyaluronic acid conjugates and technologies to suppress adsorption of...
2018/0105610 Self-Supporting, Biodegradable Film Based on Hydrophobized Hyaluronic Acid, Method of Preparation and Use Thereof
The invention relates to a self-supporting, biodegradable film comprising a C.sub.10-C.sub.22-acylated derivative of hyaluronic acid according to the general...
2018/0105609 PREPARATION OF WATER SOLUBLE TRIVALENT IRON CARBOHYDRATE COMPLEXES
The present invention provides an improved process for the preparation of Ferric carboxymaltose (FCM) complex. In this process the oxidation of maltodextrins...
2018/0105608 PROCESS FOR PRODUCING ESTERIFIED CELLULOSE ETHERS OF VERY HIGH MOLECULAR WEIGHT AND LOW VISCOSITY
A modified process for producing an esterified cellulose ether is provided which comprises the stages of i) preparing a reaction mixture comprising a cellulose...
2018/0105607 PROCESS OF PREPARING A HIGH MOLECULAR WEIGHT ESTERIFIED CELLULOSE ETHER
An esterified cellulose ether of increased weight average molecular weight is produced in a process for reacting a cellulose ether with an aliphatic...
2018/0105606 ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF
Disclosed is an antibody which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The...
2018/0105605 ANTIBODIES AND METHODS OF USE
The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the...
2018/0105604 METHODS FOR REDUCING PROTEINURIA IN A HUMAN SUBJECT SUFFERING FROM IMMUNOGLOBULIN A NEPHROPATHY
In one aspect, the invention provides methods for reducing proteinuria in a human subject suffering, or at risk of developing Immunoglobulin A Nephropathy...
2018/0105603 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HAEMORRHAGIC DISEASES
The present invention relates to a method and compositions for the treatment of haemorrhagic diseases.
2018/0105601 Antibodies That Bind Cell-Associated CA 125/O772P
The present invention provides antibodies, and antigen-binding fragments of antibodies, fusion polypeptides and analogs that preferentially bind ...
2018/0105600 ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE
Provided herein, inter alia, are isolated antibodies that bind an extracellular domain of a human SIRP-.alpha. v1 polypeptide (e.g., the D1 domain), an...
2018/0105599 IMMUNOTHERAPEUTIC MOLECULES AND USES
The invention provides molecule comprising: (i) a targeting moiety capable of directly or indirectly targeting to unwanted cells, and (ii) a further moiety...
2018/0105598 ANTI-CD133 MONOCLONAL ANTIBODIES AND RELATED COMPOSITIONS AND METHODS
Anti-CD133 monoclonal antibodies having advantageous properties; products, compositions and kits comprising the monoclonal antibodies; methods (processes) of...
2018/0105597 TGFbeta Receptor II Antibodies
The present invention relates to antibodies that bind TGF.beta. receptor II (TGF.beta.RII), and may be useful for treating cancer alone and in combination with...
2018/0105596 ANTI-TYRO3 ANTIBODIES AND USES THEREOF
The present invention relates to antibodies, in particular human or humanized antibodies, that bind to the extracellular domain of human Tyro3 receptor, in...
2018/0105595 TIME AND SPACE ADJUSTABLE SYSTEM FOR INHIBITING PATHOLOGICAL TARGET CELLS
The present invention provides a time and space adjustable system for inhibiting pathological target cells. The system comprises: (1) fusion protein,...
2018/0105594 Antibodies Against Human NKG2D and Uses Thereof
The present invention provides isolated anti-human NKG2D monoclonal antibodies useful for therapeutic applications in humans. Typically, the antibodies are...
2018/0105593 METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE...
Methods and compositions for using the MEW class II invariant chain polypeptide, Ii (also known as CD74), as a receptor for macrophage migration inhibitory...
2018/0105592 Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease
A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a...
2018/0105591 ANTI-CD47 ANTIBODIES AND METHODS OF USE
Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain...
2018/0105590 ANTIBODIES THAT BIND AND BLOCK TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-1 (TREM-1)
The invention relates to antibodies that are capable of specifically binding TREM-1 and preventing the activation of TREM-1, a protein expressed on monocytes,...
2018/0105589 HOMOGENEOUS ANTIBODY POPULATIONS
The present invention is generally directed to methods of producing an increase in the enrichment and/or recovery of preferred forms of monoclonal antibodies....
2018/0105588 METHODS OF TREATING DISEASES
This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as Crohn's Disease,...
2018/0105587 BINDING MOLECULES TARGETING PATHOGENS
A first aspect of the disclosure relates to the field of binding molecules targeted at pathogens. The disclosure further relates to proteinaceous binding...
2018/0105586 SECRETED aP2 AND METHODS OF INHIBITING SAME
A method of reducing a symptom of a clinical disorder characterized by aberrantly elevated circulating aP2 is carried out by administering to a subject an...
2018/0105585 ANTIBODIES TO AMYLOID BETA
Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid...
2018/0105584 ANTIBODY DIRECTED AGAINST IMMUNOGLOBULIN-BINDING PROTEINS OF S. AUREUS
A monoclonal antibody that counteracts Staphylococcus aureus by specifically binding to wild-type immunoglobulin-binding proteins (IGBP) of S. aureus...
2018/0105583 ANTIBODIES THAT BIND ZIKA VIRUS ENVELOPE PROTEIN AND USES THEREOF
Isolated monoclonal antibodies which bind to Zika virus envelope protein and related antibody-based compositions and molecules are disclosed. Also disclosed...
2018/0105582 THERAPEUTIC COMPOSITION
A therapeutic composition can include an herbal composition having solid material or liquid extracts from the solid material of at least one of Saussurea...
2018/0105581 MONOVALENT, BIVALENT AND TRIVALENT ANTI HUMAN RESPIRATORY SYNCYTIAL VIRUS (HRSV) NANOBODY CONSTRUCTS FOR THE...
Amino acid sequences are provided that are directed against/and or that can specifically bind protein F of hRSV, as well as to compounds or constructs, and in...
2018/0105580 FILOVIRUS THERAPY
The present invention provides antibodies, for use in the treatment, suppression prevention of Filovirus disease, particularly Ebola virus disease. Also...
2018/0105579 ANTIBODIES THAT POTENTLY NEUTRALIZE RABIES VIRUS AND OTHER LYSSAVIRUSES AND USES THEREOF
The invention relates to antibodies, and antigen binding fragments thereof that potently neutralize infection of both RABV and non-RABV lyssaviruses. The...
2018/0105578 ALBUMIN VARIANTS
The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also...
2018/0105577 ALBUMIN VARIANTS
The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also...
2018/0105576 ALBUMIN VARIANTS
The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also...
2018/0105575 METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS
The present invention relates to a method of purifying albumin-fusion proteins to reduce the level of oxidation of susceptible amino acid residues. The method...
2018/0105574 ISOLATED PEPTIDES AND FRAGMENTS THEREOF FROM FIBRINOGEN FOR USE AS DRUGS, PARTICUARLY IN SKIN INFLAMMATORY DISEASES
A present invention relates to isolated peptides obtained from human fibrinogen for their use as drug, particularly for the prevention and/or the treatment of...
2018/0105573 NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR
The present invention provides a nucleic acid construct comprising the following structure: A-X--B in which A and B are nucleic acid sequences encoding a first...
2018/0105572 NOVEL CYCLIC MONOMER AND DIMER PEPTIDES HAVING INTEGRIN ANTAGONIST ACTIVITY
The invention relates to C to N cyclized (C-N cyclic) monomer and dimer peptide molecules, as well as peptide dimers which are connected by linker moieties at...
2018/0105571 GAL-1 Variants Having Immuno-Modulating Properties and Methods of Using the Same
Galectin-1 polypeptide variants that include a mutation of the histidine residue corresponding to position 52 of the full-length amino acid sequence of native...
2018/0105570 METHOD FOR PREPARATION OF A RECOMBINANT PROTEIN FROM A PRECUSOR
The method for preparation of a recombinant protein from a precursor, preferably mammalian insulins, including human insulins and their analogues,...
2018/0105569 ANALOGS OF GLUCAGON EXHIBITING GIP RECEPTOR ACTIVITY
Provided herein are glucagon analogs which exhibit potent activity at the GIP receptor, and, as such are contemplated for use in treating diabetes and obesity....
2018/0105568 Peptide Analogs for Treating Diseases and Disorders
Provided herein are methods for the treatment of type I diabetes, Type II diabetes, metabolic syndrome, or obesity, or of appetite suppression, or for...
2018/0105567 PEPTIDE DERIVED FROM GPC3, PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF CANCER USING THE SAME,...
The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 11 and...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.